A Multicenter, Randomized Trial to Compare Xience and Vision Coronary Stents in the Same Multivessel Patient With Chronic Kidney Disease.
Latest Information Update: 14 Jan 2020
Price :
$35 *
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Therapeutic Use
- Acronyms RENAL-DES
- 01 Sep 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 03 Jun 2010 Status changed from active, no longer recruiting to recruiting as reported by ClinicalTrials.gov.
- 03 Jun 2010 Additional trial lead investigator identified as reported by ClinicalTrials.gov.